{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Rangareddy",
      "state": "",
      "country": "India",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "93868",
      "recalling_firm": "NATCO Pharma Limited",
      "address_1": "Pharma Division, Kothur Village",
      "address_2": "",
      "postal_code": "N/A",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0318-2024",
      "product_description": "Lansoprazole Delayed-Release Capsules USP, 15 mg, 14-count bottle, Manufactured by: Natco Pharma Limited Kothur- 509 228, India, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ. 08816. NDC 16571-742-41",
      "product_quantity": "4260 bottles",
      "reason_for_recall": "CGMP Deviations: Inadequate induction sealing on bottles, capsules were observed with bubbles on band seal, capsules with holes and spheres sticking to capsules. Also coding details were missing on one bottle.",
      "recall_initiation_date": "20240201",
      "center_classification_date": "20240208",
      "termination_date": "20260206",
      "report_date": "20240214",
      "code_info": "Lot # 411987 Exp:  05/2025",
      "more_code_info": ""
    }
  ]
}